Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trimodulin for Severe COVID-19
NCT04576728Phase 2Completed
- Sponsor
- Biotest AG
- Start
- Oct 2020
- Primary completion
- Jun 2021
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 4
01
Overview
A Phase 2 trial of Pentaglobin in coronavirus disease 2019 (COVID-19), sponsored by Biotest AG. Started Oct 2020; status: completed.
02
Drugs
Pentaglobin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04576728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04576728.